跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
李 薰華
助理教授
,
神經學科
主治醫師
,
臺北醫學大學附設醫院
成員
,
臺北神經醫學中心
https://orcid.org/0000-0002-1473-4799
電子郵件
kaorulei
tmu.edu
tw
No. 250 Wu-Xing Street, Taipei 11031
h-index
303
引文
11
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2013
2024
每年研究成果
概覽
指紋
網路
專案
(4)
研究成果
(45)
類似的個人檔案
(6)
指紋
查看啟用 Hsun-Hua Lee 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Acid-Sensing Ion Channel
19%
Age Distribution
19%
Allele
31%
Alpha Chain
19%
Artery Blood Flow
19%
Autophagosome
21%
Autophagy
90%
Cancer Cell
43%
Cell Death
38%
Cell Invasion
14%
Cell Migration
14%
CHRNA5
19%
Clinical Trial
19%
Cohort Study
22%
Computer Model
10%
Cytotoxic Concentration
9%
DNA Polymerase
19%
down Regulation
38%
Drive
19%
E2F
32%
Embase
19%
Gene Set Enrichment Analysis
18%
Genetic Divergence
9%
Genome-Wide Association Study
19%
Guanylate-Binding Protein
19%
Histone H2A
19%
IC50
22%
Immune Checkpoints
26%
Inflammasome
9%
Inositol Monophosphatase
19%
Luciferase
27%
Mammalian Target of Rapamycin
26%
Medline
20%
Messenger RNA
26%
Nicotinic Acetylcholine Receptor
19%
Observational Study
19%
P53
11%
Pain Receptor
12%
Phospholipase C
19%
Precursor
19%
Progression Free Survival
19%
Radiosensitivity
80%
Reverse Transcription Polymerase Chain Reaction
22%
Short Term Memory
19%
STAT1
23%
Statin
19%
Survival Rate
26%
TXNIP
19%
Upregulation
100%
Western Blot
13%
Medicine and Dentistry
Absence
20%
Acupuncture Treatment
19%
Apoplexy
21%
Artery Occlusion
19%
Autophagy
19%
Benign Paroxysmal Positional Vertigo
20%
Biological Marker
15%
Clear Cell Renal Cell Carcinoma
19%
Clinical Study
19%
Counseling
19%
Disability
25%
down Regulation
19%
Emergency Care
19%
Gait
19%
Geriatrics
19%
Glioblastoma
19%
Guanine Nucleotide Binding Protein
19%
Gut Microbiota
19%
Hip Fracture
19%
Histone H2A
19%
Inositol
19%
Japanese Encephalitis
19%
Japanese Encephalitis Virus Group
19%
Lung Adenocarcinoma
19%
Malignant Neoplasm
25%
Medicine
19%
Meta-Analysis
19%
Mobilization
19%
Mouth Squamous Cell Carcinoma
38%
Neurologic Disease
19%
Nodular Melanoma
38%
Observational Study
19%
Oral Cancer
19%
Outpatient
19%
Ovarian Cancer
19%
Paclitaxel
19%
Parkinson's Disease
19%
Positional Vertigo
19%
Programmed Cell Death
38%
Programmed Death 1 Ligand 1
19%
Radiosensitivity
29%
Ramsay Hunt Syndrome
19%
Rehabilitation Engineering
19%
Rifaximin
19%
STAT1 Protein
19%
Systematic Review
19%
Temozolomide
19%
Traumatic Brain Injury
19%
Upregulation
46%
Vestibular Neuronitis
19%
Pharmacology, Toxicology and Pharmaceutical Science
Apolipoprotein E
19%
Artery Occlusion
19%
Atractylodes Macrocephala Extract
19%
Biological Marker
29%
Brain Ischemia
19%
Cancer Growth
20%
Castration Resistant Prostate Cancer
19%
Chemotherapy
11%
Chronic Fatigue Syndrome
19%
Clinical Study
19%
Cohort Study
22%
DNA Polymerase
19%
Docetaxel
19%
Epidermal Growth Factor Receptor
19%
Glioblastoma
19%
Guanine Nucleotide Binding Protein
19%
Immune Checkpoint Inhibitor
12%
Inflammation
19%
Inositol
19%
Intestine Flora
19%
Lactoferrin
19%
Luciferase
11%
Malignant Neoplasm
10%
Medical Prescription
19%
Melanoma
19%
Mouse
15%
Mouth Cancer
19%
Mouth Squamous Cell Carcinoma
38%
Observational Study
19%
Osimertinib
19%
Ovary Cancer
19%
Oxcarbazepine
11%
Paclitaxel
33%
Parkinson's Disease
38%
Preclinical Study
19%
Programmed Cell Death
19%
Programmed Death 1 Ligand 1
19%
Receptor
19%
Remission
19%
Renal Cell Carcinoma
38%
Rifaximin
19%
Rikkunshito
19%
Sleep Disorder
19%
STAT1 Protein
19%
Statin (Protein)
19%
Teratogenesis
19%
Traditional Chinese Medicine
19%
Traumatic Brain Injury
19%
Triple Negative Breast Cancer
19%
Zebra Fish
19%
